We are an applied encryption company that serves and protects the most important institutions in the world.
Hoth Technologies builds privacy preserving software for sovereign individuals and institutions. In a digital world where data collection is the default, we believe end-to-end encryption and other privacy preserving techniques are no longer optional.
Total raised
$18.0M
Last stage
Seed
Investors
Robb Knie
Robb Knie is the President, CEO, and Chair of Hoth Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on developing therapies for unmet medical needs including skin disorders, oncology, and neurology.
David B. Sarnoff
David B. Sarnoff serves as a Director at Hoth Therapeutics, Inc., supporting the company's mission in early-stage pharmaceutical research and development.
No applications, no recruiter spam. Just the intro.
A few questions to make sure this role is the right shape for you. Two minutes.
I write the intro, send it to the founder, and handle the back-and-forth.
If they’re a yes, I book the chat. You show up — that’s the whole job-hunt.
